Sitemap

Nicolas Marquier, Regional Manager for the Western Balkans at the International Finance Corporation (IFC)

Financing the Future

IFC, the largest global development institution, has provided almost $1 billion in financing to Serbia’s private sector over the past six years IFC, as a...

Dr Ivan Todorović, Todorović Law Firm

Dedicated Advisors and Tenacious Litigators

The Todorović Law Firm has existed for more than 30 years and throughout that time has demonstrated its unwavering dedication to continuously advancing at...

Marija Stojiljković, Founder, Royal Nanny

Children Deserve the Best Nannies

Royal Nanny offers a wide range of childcare services, primarily through mediating between professional nannies and families, providing responsible, meticulous, trained and caring individuals Starting...

Petar Miljković, CEO, 14. Oktobar d.o.o.

Employees are the Company’s Real Strength

This former Kruševac giant, which has come a long way over the course of 100 years of operations, developing from a construction machinery factory...

Ivana Bogdanović, Director of Marketing and Corporate Communications at Addiko Bank

CSR as a Longstanding Priority

In today’s world, where gaining the trust of clients is the most important aspect of a company’s business, CSR, or socially responsible operations, represents...

Nebojša Škuljec, Director, Merck Sharp & Dohme

Committed To Patients’ Health In Serbia

For 130 years, Merck Sharp & Dohme has been inventing for life, bringing medicines and vaccines for many of the world’s most challenging diseases in the pursuit of its company mission to save and improve lives

We need to continue in the same direction, and once we close the gap on EU countries, we need to have continuous and sustainable investment behind innovation, in parallel with reducing inefficiencies in the healthcare system,” says Merck Sharp & Dohme Director Nebojša Škuljec.

Has the pharmaceutical industry been working over the past year to develop new therapies for diseases that we neglected and disregarded as a result of the arrival of COVID-19?

Prior to COVID-19, most resources and efforts were focused on developing new drugs for oncology and non-communicable diseases. MSD made a breakthrough in oncology treatment several years ago, with the development of the first immunooncology drug, Keytruda®, which showed remarkable results that have been confirmed by the now five-year survival data on some of the deadliest forms of cancer, such as malignant melanoma and lung cancer. We’re continuing to investigate and demonstrate the benefits of Keytruda® in a range of malignant diseases, but we’ve also strengthened our commitment to fighting infectious diseases. In parallel with developing new powerful antibiotics that are needed to address growing antimicrobial resistance, MSD is investing a lot of effort into delivering quickly on the new potent anti-COVID drug. Our Molnupiravir molecule has been shown to be active in several models of SARS-CoV-2.

Patients in the U.S. can take advantage of the availability of the latest therapies. How can we reduce the availability gap compared to such developed countries?

Besides investing in the development of new medicines, it is also important that innovations are accessible and affordable to the patients who need them. Spending on medicines as a percentage of overall healthcare expenditure ranges from five to 10 percent in most developed countries, to as much as 60 percent in many emerging economies.

Merck Sharp & Dohme aspires locally to be the most-trusted partner to Serbian Government, healthcare institutions and health workers

All healthcare systems worldwide aim to secure mechanisms to control healthcare costs while serving the need for breakthrough treatments. Serbia has come a long way in the past several years, in terms of access to innovative medicines, followed by increased investment that has resulted in much better outcomes for patients.

The second important task for policymakers and the pharmaceutical industry is to expand public-private partnerships, like the latest one coming from our company, which relates to the aforementioned anti-COVID drug Molnupiravir. We believe that this kind of partnership, as well as advanced purchase agreements, are also possible in other countries, and we are actively engaged in numerous efforts to ensure Molnupiravir is also available in Serbia, immediately after global healthcare giants like the U.S.

Are you preparing to celebrate the 25th anniversary of your operations in Serbia? What is behind you, and what lies ahead?

We’ve demonstrated the same commitment to patients and the health of the population in Serbia over the past 25 years by increasing access to healthcare through far-reaching policies, programs and partnerships. Today, we continue to be at the forefront of research aimed at preventing and treating diseases that threaten people’s lives, just as we also aspire locally to be the most-trusted partner of the Serbian Government, healthcare institutions and health workers.

Nicolas Marquier, Regional Manager for the Western Balkans at the International Finance Corporation (IFC)

Financing the Future

IFC, the largest global development institution, has provided almost $1 billion in financing to Serbia’s private sector over the past six years IFC, as a...

Dr Ivan Todorović, Todorović Law Firm

Dedicated Advisors and Tenacious Litigators

The Todorović Law Firm has existed for more than 30 years and throughout that time has demonstrated its unwavering dedication to continuously advancing at...

Marija Stojiljković, Founder, Royal Nanny

Children Deserve the Best Nannies

Royal Nanny offers a wide range of childcare services, primarily through mediating between professional nannies and families, providing responsible, meticulous, trained and caring individuals Starting...

Petar Miljković, CEO, 14. Oktobar d.o.o.

Employees are the Company’s Real Strength

This former Kruševac giant, which has come a long way over the course of 100 years of operations, developing from a construction machinery factory...

Galenika Strengthens Market Position with New Strategic Partnerships

Galenika has significantly expanded its presence in the pharmaceutical sector by securing an exclusive distribution agreement with Cantabria Labs,...

HDZ Claims Victory in Croatian Elections but Lacks Majority

The Croatian Democratic Union (HDZ), the country's ruling party, emerged as the winner in Wednesday's parliamentary elections. Despite their...

Milšped Group Launches Direct Rail Line Between China and Serbia

Milšped Group, a leader in regional transportation and logistics, has announced a new partnership with Shijiazhuang International Land Port...

French Embassy and Institute in Serbia Launch ‘Rhythm of French Culture’ Event Series

The French Embassy and the French Institute in Serbia are organising an event called Rhythm of French Culture. This year,...

Albania to Utilize Drones in Anti-Cannabis Campaign

Albania is set to enhance its anti-cannabis efforts by deploying advanced drone technology, announced Interior Minister Taulant Bala. Starting...

Maserati’s Balkan Expansion: New Showroom Opens in Belgrade

Delta Auto Group has unveiled an exclusive Maserati showroom in Belgrade, setting new luxury benchmarks in line with the...

Peter Pellegrini Wins Slovak Presidential Election

Peter Pellegrini, the candidate from the ruling coalition, won the second round of the presidential elections in Slovakia, securing...

Strategic Energy Partnership Established Between Serbia and France

The Serbian Government adopted a Memorandum of Understanding between the Government of Serbia and French Electric Power Company (EDF),...

Serbia-France Innovation Forum Begins: Innovate for the Planet! Play Green!

At the Serbia-France Innovation Forum titled 'Innovate for the Planet, Play Green', which commenced at the Palace Serbia, French...

EU and EP Finalise €6 Billion Support for Western Balkans

The European Parliament and the Council of the European Union have finalised a deal to provide an additional six...

Maserati’s Balkan Expansion: New Showroom Opens in Belgrade

Delta Auto Group has unveiled an exclusive Maserati showroom in Belgrade, setting new luxury benchmarks in line with the...

Peter Pellegrini Wins Slovak Presidential Election

Peter Pellegrini, the candidate from the ruling coalition, won the second round of the presidential elections in Slovakia, securing...

Strategic Energy Partnership Established Between Serbia and France

The Serbian Government adopted a Memorandum of Understanding between the Government of Serbia and French Electric Power Company (EDF),...

Serbia-France Innovation Forum Begins: Innovate for the Planet! Play Green!

At the Serbia-France Innovation Forum titled 'Innovate for the Planet, Play Green', which commenced at the Palace Serbia, French...

EU and EP Finalise €6 Billion Support for Western Balkans

The European Parliament and the Council of the European Union have finalised a deal to provide an additional six...
spot_img